Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. (NASDAQ: SLXN) is trading at $0.26, about ₹25 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 1.28% today. Indian residents can buy Silexion Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$0.24
Today's high
$0.27
52 week low
$0.24
52 week high
$42.60
SLXN opened at $0.24, closed previously at $0.26, and has traded between $0.24 and $42.60 over the past 52 weeks.
About
Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: SiG12D-LODER, which has progressed through both preclinical studies and an open-label Phase I clinical trial for pancreatic cancer; Prostate-LODER, currently undergoing preclinical evaluation for prostate cancer; and GBM-LODER, also in preclinical development, targeting Glioblastoma Multiforme, a highly malignant primary brain tumor. Founded in 2008, Silexion Therapeutics is headquartered in Jerusalem, Israel.
Key statistics
Avg. volume
3.50M
Market cap
$109.06K
P/E Ratio
-0.00
Price-to-sales ratio
0.00
Enterprise value
-$709.93K
Free cash flow yield
-11398.71%
Debt-to-equity ratio
32.05
Return on equity
-563.11%
ROIC
628.40%
Beta
-0.25
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$0.00
Earnings per share
-$89.60
Free cash flow
-$10.83M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-$11.88M
Revenue growth
—
Similar securities
This is not an investment recommendation
How to buy Silexion Therapeutics from India
Indian residents can buy Silexion Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Silexion Therapeutics and place an order
Find Silexion Therapeutics by name or by its ticker, SLXN, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Silexion Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Silexion Therapeutics position in USD and INR. Silexion Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Silexion Therapeutics from India
Trading and taxes when buying Silexion Therapeutics from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneSilexion Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Silexion Therapeutics stock?
Yes. Silexion Therapeutics (SLXN) has been listed on NASDAQ since 2024, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Silexion Therapeutics share cost in rupees?
One Silexion Therapeutics share is $0.26 — about ₹25 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Silexion Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Silexion Therapeutics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Silexion Therapeutics?
Yes. One Silexion Therapeutics share is $0.26, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Silexion Therapeutics.
How are gains on Silexion Therapeutics shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Silexion Therapeutics price. Paasa issues a capital-gains statement for your return.
Does Silexion Therapeutics pay a dividend?
No. Silexion Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Silexion Therapeutics from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Silexion Therapeutics a United States company, and does that change how it is taxed?
Silexion Therapeutics trades on NASDAQ in US dollars, but the company is domiciled in Israel. Silexion Therapeutics trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Silexion Therapeutics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Silexion Therapeutics holding, its cost and its closing value.
How do I sell Silexion Therapeutics and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.